DNA modifications: Another stable base in DNA.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

4 citing papers in PubMed.

1. Liquid Biopsies beyond Mutation Calling: Genomic and Epigenomic Features of Cell-Free DNA in Cancer.Cancers · 2021
   Review
2. 5-hydroxymethylcytosine marks regions with reduced mutation frequency in human DNA.eLife · 2016
   Article
3. Evidence from clinical and animal model studies of the long-term and transgenerational impact of stress on DNA methylation.Seminars in cell & developmental biology · 2015
   Review
4. The long-term impact of adverse caregiving environments on epigenetic modifications and telomeres.Frontiers in behavioral neuroscience · 2015
   Review

Corrections and comments

• Comment on
  5-Hydroxymethylcytosine is a predominantly stable DNA modification.2014

Authors and funding

2 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as